Tiantao Zhang | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Prof. Tiantao Zhang | Microbial Cell Biology | Best Researcher Award

Prof. Tiantao Zhang, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, China

Dr. Tiantao Zhang is a prominent agricultural entomologist specializing in the management of maize pests and pest resistance. He earned his doctoral degree in Agricultural Entomology and Pest Control from Northwest A&F University, followed by a post at the Chinese Academy of Agricultural Sciences. His research spans pest population dynamics, resistance to Bt and pesticides, and climate-induced pest behavior. A dedicated scientist with international exposure at the University of California, Davis, Dr. Zhang has led national research programs and published extensively in peer-reviewed journals. His work combines field experimentation with molecular and ecological approaches, contributing to sustainable pest management in China and beyond. Dr. Zhang’s scientific leadership and commitment to solving agricultural challenges position him as a standout researcher in plant protection and pest ecology.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Proven Scientific Expertise:
    Dr. Zhang has over 15 years of focused research in agricultural entomology, particularly in maize pest management—an area critical to global food security.

  2. Leadership in National Projects:
    He is the Principal Investigator of two major National Key R&D Programs of China (2023–2026 and 2025–2028), demonstrating trust from national research institutions and strong project management capability.

  3. Research Innovation and Relevance:
    His work on pest population prediction, diapause regulation, and resistance mechanisms to Bt toxins and pesticides addresses urgent agricultural challenges in the face of climate change and biotechnology deployment.

  4. Global Collaboration:
    His tenure as a visiting scholar at the University of California, Davis (2018–2019) highlights international research engagement and cross-cultural collaboration.

  5. Strong Publication Record:
    Dr. Zhang has published in respected international journals including Scientific Data, Biology, Toxins, and Entomologia Generalis. He covers molecular biology, ecology, and toxicology, reflecting interdisciplinary research breadth.

⚠️ Areas for Improvement:

  1. Increased Global Visibility:
    While his research is of high quality, expanding participation in international symposia and authoring high-impact reviews could increase visibility and citation impact.

  2. Data Sharing and Open Science:
    Strengthening the availability of raw data and modeling tools (e.g., pest prediction models) through open-access repositories would amplify his research utility and recognition.

  3. Mentorship and Outreach:
    Highlighting his role in mentoring young scientists, if applicable, would further support his candidacy as a well-rounded researcher contributing to capacity building.

🎓 Educational Background:

Dr. Zhang’s educational foundation is deeply rooted in plant protection and entomology. He earned his Bachelor of Agriculture degree in Plant Protection from Shihezi University in 2005. Driven by a passion for integrated pest management, he pursued graduate studies at Northwest A&F University, completing a Master of Agriculture (2008) and a Doctor of Agriculture (2011), both in Agricultural Entomology and Pest Control. His academic journey honed his expertise in pest population dynamics, ecological interactions, and biochemical resistance mechanisms. Dr. Zhang’s education laid the groundwork for his future contributions to pest forecasting, Bt resistance research, and sustainable agriculture, bridging traditional agricultural sciences with modern molecular approaches.

💼 Working Experience:

Since December 2011, Dr. Zhang has been a core member of the Corn Insect Pest Laboratory at the Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing. In this role, he has been instrumental in national research projects on maize pest control and climate-responsive pest behavior. Between 2018 and 2019, he broadened his academic perspective as a visiting scholar at the University of California, Davis, where he engaged in collaborative research on pest resistance. His long-standing involvement with the national plant protection institute has enabled him to lead high-profile studies, publish widely, and mentor emerging researchers. Dr. Zhang’s professional trajectory reflects deep commitment, research leadership, and a forward-looking approach to pest ecology and resistance management.

🔬 Research Focus:

Dr. Zhang’s research revolves around sustainable pest management in maize, targeting major pests like Ostrinia furnacalis, Conogethes punctiferalis, and Spodoptera frugiperda. His work delves into pest population dynamics, occurrence modeling, diapause regulation, and early warning systems. A central theme is the genetic and ecological basis of resistance to Bt toxins and chemical pesticides. He investigates resistance selection mechanisms, gene expression changes, and molecular adaptation pathways. Recently, his research expanded into pest responses to climate change, particularly voltinism and diapause shifts. Dr. Zhang integrates entomology, genomics, toxicology, and data modeling to enhance pest forecasting and resistance management. His efforts support China’s food security and contribute globally to environmentally responsible crop protection.

📚 Publications Top Notes: 

  1. 🧬 The function of ABCD3 transporter in the insecticidal process of Bt toxins – Entomologia Generalis, 2023

  2. 🌡️ Intra-population alteration on voltinism of Asian corn borer in response to climate warming – Biology, 2023

  3. 🧬 Chromosome-level genome of a multivoltine biotype Ostrinia furnacalis strain – Scientific Data, 2025

  4. ❄️ Evolutionary shift of insect diapause strategy in a warming climate – Biology, 2023

  5. 🍑 Artificial diet development for mass rearing of yellow peach moth – Entomological Research, 2021

  6. 🧪 Phenotypic responses of lepidopterans to graphene oxide exposure – Ecotoxicology and Environmental Safety, 2021

  7. 🛡️ Down-regulation of aminopeptidase N and ABC transporter in Bt-resistant Asian corn borer – Int. J. Biological Sciences, 2017

  8. 🧲 Binding affinity of five PBPs to Ostrinia sex pheromones – BMC Molecular Biology, 2017

  9. 🧫 Structure-function analysis of MhieJHAMT enzyme in juvenile hormone biosynthesis – Int. J. Biological Macromolecules, 2025

  10. 🦠 Differential characterization of midgut microbiota in Bt-resistant vs. susceptible Ostrinia furnacalis – Insects, 2025

🧾 Conclusion:

Dr. Tiantao Zhang is a highly qualified and deserving candidate for the Best Researcher Award. His leadership in national research programs, his impactful contributions to pest resistance and ecological forecasting, and his consistent scholarly output place him among the top researchers in agricultural sciences. With strategic focus on enhancing his international visibility and interdisciplinary collaborations, Dr. Zhang is not only contributing to China’s agricultural sustainability but also to global crop protection research.

PANAGIOTA TSIATSIOU | Host-Pathogen Interactions | Best Researcher Award

Posted on by Cell Biologist

Dr. PANAGIOTA TSIATSIOU | Host-Pathogen Interactions | Best Researcher Award

Dr. PANAGIOTA TSIATSIOU, AHEPA UNIVERSITY HOSPITAL, Greece

Dr. Panagiota Tsiatsiou is a dedicated medical biopathologist with over two decades of service in the Greek National Health System. Born on March 17, 1969, in Thessaloniki, Greece, she earned her M.D. from the Aristotle University of Thessaloniki and has specialized in hematology diagnostics, molecular biology, and public health. Since 2011, she has served in the Hematology Section at AHEPA University Hospital and was appointed Director in 2018. Her role extends beyond diagnostics to include leadership, training of residents, and managing lab operations, especially during the COVID-19 pandemic. With three Master’s degrees and active participation in scientific publications and conferences, Dr. Tsiatsiou continues to bridge clinical practice and research. Her work on angiopoietins and biomarkers in COVID-19 patients demonstrates her commitment to innovative healthcare solutions and translational medicine.

Publication Profile: 

Scopus

Orcid

✅ Strengths for the Award:

  1. Extensive Clinical and Laboratory Expertise
    Over 20 years of experience in microbiology and hematology laboratories, with advanced specialization in Medical Biopathology, PCR techniques, and molecular hematology.

  2. Research Impact in COVID-19
    Lead author in two recent international peer-reviewed publications (2024, 2025) on angiopoietins and endothelial damage in COVID-19—topics of significant relevance in post-pandemic biomedical research.

  3. Academic Qualifications
    Holder of three Master’s degrees in Health Services Management, Public Health, and Biomedical Sciences—demonstrating a strong interdisciplinary foundation and commitment to academic excellence.

  4. Mentorship and Leadership
    Director of the Hematology Section at AHEPA University Hospital since 2018; deeply involved in resident training and lab coordination, especially during the pandemic, proving strong leadership under crisis.

  5. Scientific Contribution

    • 6 publications (4 international, 2 Greek)

    • 99 scientific papers

    • Participation in 158 scientific conferences, workshops, and seminars—highlighting strong engagement with the research community.

⚠️ Areas for Improvement:

  1. Global Visibility
    While research quality is high, international recognition could be improved by targeting higher-impact journals and expanding collaborations outside Greece.

  2. Grants and Funding Leadership
    CV does not specify involvement in research grant acquisition or project funding management—which are often critical metrics in high-level research awards.

  3. Innovation and Patents
    There is no mention of patents, technological innovation, or industry partnerships, which could further enhance her scientific portfolio.

  4. Broader Publication Scope
    Expanding beyond COVID-19-related studies to publish more widely in hematologic and molecular diagnostics would strengthen her long-term research narrative.

🎓 Education:

Dr. Tsiatsiou holds a solid educational background in medicine and public health. She completed her M.D. at the Aristotle University of Thessaloniki (1988–1995), followed by rural service and specialization in Medical Biopathology at Theageneio Anticancer Hospital, obtaining her board certification in 2002. She pursued a Master’s in Health Services Management (2005–2008) at the Hellenic Open University, focusing on blood donor psychology. She furthered her expertise with a Master’s in Public Health at the National School of Public Health, where she studied foodborne infections. Additionally, she obtained a Master’s in Biomedical Sciences with a concentration in Diagnosis and Therapy, focusing on genetic mutations like FV Leiden. Her academic trajectory reflects a deep interdisciplinary approach—combining clinical knowledge, health systems, and research.

🏥 Experience:

Dr. Tsiatsiou’s clinical career spans more than 20 years, primarily within Greece’s National Health System. From 2003 to 2020, she served in various microbiology labs, refining her diagnostic skills. Since July 2011, she has worked in the Hematology Section at AHEPA University Hospital, leading the unit since 2018. Her expertise includes hemostasis, hemoglobinopathies, and molecular testing, and she has been instrumental in staff training and lab management. She led the hemostasis lab during the COVID-19 pandemic, ensuring continuity and quality of diagnostics under pressure. Her dedication to resident education in both Medical Biopathology and General Medicine has made her a respected mentor. Dr. Tsiatsiou’s leadership has elevated the lab’s scientific output, and her involvement in over 150 conferences showcases her engagement with ongoing medical developments.

🔬 Research Focus:

Dr. Tsiatsiou’s research is centered on hematology diagnostics, hemostasis disorders, and molecular markers in infectious diseases. Her most recent work investigates endothelial damage and angiopoietin levels as predictors in COVID-19 patients during the Delta and Omicron waves. This research bridges laboratory medicine with clinical outcomes, offering vital insights into disease severity and prognostics. She also explores genetic predispositions, such as FV Leiden mutations, in thrombotic risk profiling. Her postgraduate theses and training in PCR and molecular hematology underscore her commitment to translational science. With 6 peer-reviewed publications and 99 scientific papers, her academic output is diverse and impactful. Dr. Tsiatsiou’s multidimensional research contributes not only to hematology but also to public health and epidemiology, making her work highly relevant in modern medicine and worthy of recognition.

📚 Publications Top Notes:

  1. 📄 Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients, Current Issues in Molecular Biology, 2025

  2. 📄 Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves, Current Issues in Molecular Biology, 2024

  3. 📄 Thesis: Trends, Attitudes, and Motivations of Blood Donors and Non-Donors – Hellenic Open University

  4. 📄 Thesis: Foodborne Infections in Urban and Rural Populations of Central Macedonia – National School of Public Health

  5. 📄 Thesis: Prevalence of FV Leiden Mutation in a Tertiary Hospital – Democritus University of Thrace & IHU

  6. 📄 Additional 99 scientific papers and 158 participations in academic events

🧾 Conclusion:

Dr. Panagiota Tsiatsiou is a highly qualified and impactful researcher with significant contributions in hematology, molecular diagnostics, and public health. Her recent publications in Current Issues in Molecular Biology show scientific depth and relevance, especially regarding the clinical progression of COVID-19. She is an excellent candidate for a national or institutional Best Researcher Award, particularly in medical diagnostics and laboratory medicine.

Drosos Kourounis | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Mr. Drosos Kourounis | Microbial Cell Biology | Best Researcher Award

Mr. Drosos Kourounis | Hellenic Pasteur Institute| Greece

Drosos Kourounis is a seasoned biomedical scientist based at the Hellenic Pasteur Institute, Greece. With a strong foundation in molecular biology, his career has spanned from research on parasitic protozoa to developing air purification technologies for public health. His journey began with a BSc and MSc in Biology from the University of Athens, focusing on Leishmania molecular mechanisms. He progressively transitioned into applied research and pharmaceutical quality control, currently serving as the QA/QC Manager at the Hellenic Pasteur Institute. Alongside his scientific duties, he has actively participated in several national seminars and certifications in ISO standards and laboratory quality systems. His contributions to publications, including work on UV-C air disinfection and pathogen bioaerosols, show his commitment to translational science and public health safety. Kourounis’s multidisciplinary skills, research impact, and quality-driven mindset make him a standout figure in the field of biomedical research.

Publication Profile:

Ocrid

✅ Strengths for the Award:

  1. Diverse Research Portfolio: Dr. Kourounis combines basic molecular biology research (e.g., Leishmania donovani protein characterization) with applied public health innovations, such as UVC air filtration devices.

  2. Peer-Reviewed Publications: Multiple first- and co-author publications in reputable journals like International Journal of Molecular Sciences and Clinical Research and Reviews highlight his consistent research productivity.

  3. Quality & Regulatory Expertise: His role as QA/QC Manager and extensive ISO training show strong competence in scientific quality assurance, a rare but highly valuable skill in biomedical research.

  4. Public Health Impact: His work on airborne microbial bioaerosols reduction is highly relevant to healthcare, particularly in post-pandemic times.

  5. Academic Excellence: Achieved a 10/10 thesis grade for MSc research and has shown continued academic engagement and scientific rigor.

🛠️ Areas for Improvement:

  1. More International Collaborations: While his current network is strong locally, expanding his collaborations globally would increase visibility and cross-disciplinary impact.

  2. Greater Research Specialization: A more narrowly defined focus could strengthen academic identity and make his profile stand out further among specialized researchers.

  3. Funding and Grants: No mention of securing independent grants or fellowships, which are key indicators of research independence and innovation leadership.

🎓 Education:

Drosos Kourounis holds both a Bachelor of Science (2013) and Master of Science (2017) in Biology from the University of Athens, Greece. His MSc focused on molecular parasitology, specifically the cloning and characterization of a secreted nexin-like protein from Leishmania donovani, which earned him a perfect thesis score (10/10). Complementing his formal education, Kourounis has pursued multiple professional certifications in laboratory quality systems, including ISO 17025 and ISO/IEC 17025 accreditation seminars, conducted by institutions like TUV HELLAS and HellasLab. In 2021, he also completed certified training in laboratory animal science at the Hellenic Pasteur Institute, showing his commitment to ethical and regulatory compliance in biomedical research. His training portfolio demonstrates a keen interest in continuous education and the application of scientific standards in both academic and industrial environments. His educational journey reflects a balance between foundational science and regulatory excellence.

💼 Experience:

Drosos Kourounis has over 7 years of cumulative experience in biomedical research and quality control. He is currently the Quality Assurance and Quality Control Manager at the Hellenic Pasteur Institute (since January 2023), where he oversees pharmaceutical QC processes. Previously, he served as Senior QC Analyst (2022) and QC Analyst (2019–2021) at the same institution. His earlier roles include Scientific Collaborator at MEGALAB S.A. and Research Assistant at the Intracellular Parasitism group in the Hellenic Pasteur Institute. During his research tenure, he contributed to molecular studies on Leishmania donovani and the development of innovative air disinfection systems. He is recognized for his dual role as a scientist and regulatory professional, combining rigorous lab work with compliance to ISO standards. His professional trajectory showcases a steady progression toward leadership in quality control, along with consistent scientific contributions to public health and infectious disease research.

🔬 Research Focus:

Drosos Kourounis’s research lies at the intersection of molecular parasitology, bioaerosol control, and public health technology. His academic work began with the cloning and analysis of Leishmania donovani proteins, contributing to the understanding of host-parasite interactions. Transitioning from pure biology, his focus expanded to the development of innovative air disinfection technologies, including UV-C integrated filtration systems aimed at mitigating microbial exposure in clinical and public environments. This shift highlights a commitment to translational research that addresses real-world problems, such as hospital-acquired infections and airborne pathogen control. His contributions are evident in publications across molecular sciences and applied electromagnetics. Moreover, he incorporates quality assurance principles into his scientific work, ensuring research reproducibility and compliance with international standards.

📚 Publication Top Notes: 

  • 🧬 Cloning and molecular characterization of the secreted nexin-like protein LdPIBPnex, from the protozoon Leishmania donovani

  • 🌬️ Substantial Reduction of Airborne Microbial Bioaerosols by Using a Novel Combination of Air Filtration and UV Irradiation Technology in Areas of Public Interest

  • 🧫 Characterization of the First Secreted Sorting Nexin Identified in the Leishmania Protists

  • 🏥 A Study on the Reduction of Airborne Microbial Bioaerosols at Indoor Air of Hospital’s Intensive Care Unit by Using Novel Air Filtration and UV Irradiation Technology

  • 😷 Design and Analysis of a Protecting Breathing Device (VITER) Disinfecting Air with an Integrated UVC Radiation Mechanism

 

🧾 Conclusion:

Dr. Drosos Kourounis demonstrates exceptional dedication to biomedical research, quality assurance, and innovation in public health safety. His dual focus on molecular parasitology and technological solutions for microbial air control showcases both scientific depth and societal impact. With a growing publication record and leadership role in a premier research institute, he is well-positioned for recognition. Enhancing global visibility and grant acquisition could elevate his profile further. Overall, he is highly suitable and deserving of serious consideration for the Best Researcher Award.

Amal Zaher | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Amal Zaher | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Amal Zaher , Beni-suef University , Egypt

Dr. Amal Zaher Shehata Mohamad is an Egyptian chemical and environmental engineering researcher with over two decades of academic and industrial experience. Born on March 6, 1978, she currently serves as an Associate Professor at the Department of Environmental Science and Industrial Development, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Egypt. Dr. Zaher’s work bridges environmental sustainability and nanotechnology, focusing on wastewater treatment and advanced material applications. With a strong background in safety and occupational health, her research integrates real-world industry needs with academic innovation. She has published extensively in high-impact journals and has contributed to book chapters and international conferences. Her collaborative nature and interdisciplinary expertise have made her a respected voice in environmental science across Egypt and beyond.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Extensive Research Output: Dr. Zaher has authored over 20 peer-reviewed articles, conference papers, and book chapters, covering highly relevant environmental topics like wastewater treatment, nanotechnology, and advanced materials.

  2. Interdisciplinary Expertise: She bridges chemical engineering and environmental science, with a strong focus on Layered Double Hydroxides (LDHs), MOFs, nanofibers, and photocatalysis, demonstrating deep technical versatility.

  3. Real-World Relevance: Her research is oriented toward practical environmental applications—such as the degradation of pollutants and water purification—contributing to sustainable development and public health.

  4. Longstanding Academic and Industrial Experience: Dr. Zaher combines over 20 years of experience in engineering practice, health & safety, and academic teaching, giving her research both depth and applicability.

  5. Global Contributions: Participation in international conferences and publication in high-impact journals (e.g., Fuel, Scientific Reports, Environmental Science and Pollution Research) demonstrates global recognition.

  6. Leadership and Mentorship: As an Associate Professor, she plays a key role in mentoring postgraduate students, leading interdisciplinary projects, and promoting research at Beni-Suef University.

🔄 Areas for Improvement:

  1. International Collaborations: While she has collaborated widely within Egypt, expanding joint projects with international institutions or labs would elevate her global research profile.

  2. Patent or Commercial Applications: Filing patents or translating her nanomaterials research into industrial or commercial solutions would further enhance her impact.

  3. Research Funding and Grants: More visibility in securing or leading national/international research grants would strengthen her academic leadership credentials.

  4. Citation Impact: While she publishes frequently, focused efforts on publishing in journals with higher citation indices or review papers may increase her scientific impact.

🎓 Education:

Dr. Amal Zaher holds a B.Sc. with Honors in Chemical Engineering from Minia University, Egypt (2000). She later earned her M.Sc. in Chemical Engineering from the same institution in 2006 with a thesis focused on innovative techniques for treating oil-polluted wastewater. Driven by her interest in sustainable environmental technologies, she continued her academic pursuits and received her Ph.D. in Environmental Science and Industrial Development, further enhancing her knowledge in advanced oxidation processes and nanomaterials for wastewater treatment. Her educational background merges rigorous engineering principles with environmental applications, making her a versatile researcher in tackling industrial pollution challenges. Her academic training provided the foundation for a distinguished career in teaching, safety management, and cutting-edge scientific research.

💼 Experience:

Dr. Amal Zaher began her professional journey as a freelance engineer (2000–2002) before working as a specialist in safety and occupational health at the Manpower and Immigration Department in Minia, Egypt (2002–2016). She transitioned into academia in 2013 as an Assistant Professor at the Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University (BSU), later promoted to Associate Professor. With her diverse background, she has contributed significantly to environmental safety and pollution control both in practice and in theory. Her hands-on experience in industrial environments enhances her teaching and research, enabling her to address real-world problems with academic solutions. Dr. Zaher has led and collaborated on numerous projects related to wastewater treatment, nanomaterials, and environmental remediation, establishing herself as an expert and mentor in the field.

🔬 Research Focus:

Dr. Amal Zaher’s research centers around advanced materials and processes for environmental remediation, particularly in water and wastewater treatment. Her work explores the use of layered double hydroxides (LDH), metal-organic frameworks (MOFs), and nanostructures in removing pollutants like heavy metals, pharmaceuticals, and dyes. She is known for her contributions to photocatalytic degradation using processes such as Photo-Fenton and her innovative use of zeolite templates and metal doping to enhance adsorptive efficiency. Her recent projects delve into electrocatalytic and antibacterial applications of nanomaterials, as well as solar desalination. Her multidisciplinary approach—combining chemical engineering, environmental science, and materials chemistry—supports sustainable water management. Through publications, book chapters, and international presentations, Dr. Zaher has advanced global knowledge on pollution control and eco-friendly technologies.

📚 Publications Top Notes:

  1. ⚗️ Using Advanced Oxidation Process for Oily Water Clean-up

  2. 🌿 Optimization of a Simulated Photo-Fenton Process for Treating Olive Mill Wastewater

  3. 🔬 Influences of Tungsten Incorporation on Ni/C Nanostructures for Urea Elimination

  4. 💊 Zn/Fe LDH for Removal of Oxytetracycline: Experimental & Molecular Simulations

  5. 🌞 Photocatalytic Degradation of Phenol Wastewater: Photo Fenton Optimization

  6. 🧪 Nickel Doped Carbon Nanofibers with Tungsten for Ethanol Oxidation

  7. 💧 La-doped Zn-Fe LDH for Tetracycline Adsorption from Water

  8. 🧱 LDH Nanocubes with Zeolite Templates for Adsorbent Applications

  9. 🎨 Physicochemical Properties of Zn–Fe LDH for Dye Removal

  10. 🧼 Photocatalytic Degradation of Dye Wastewater with ZnO Nanoparticles

📌 Conclusion:

Dr. Amal Zaher Shehata Mohamad is a highly suitable candidate for the Best Researcher Award. Her work stands out for its relevance, innovation, and impact in solving critical environmental challenges through scientific research. With her impressive record of publications, dedication to teaching and mentoring, and alignment with sustainable development goals, she exemplifies the caliber of a leading researcher. Addressing a few strategic improvements could make her a globally recognized name in environmental science and nanotechnology.

Eman El-Wakil | Microbiology | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Eman El-Wakil | Microbiology | Best Researcher Award

Assoc. Prof. Dr. Eman El-Wakil , Theodor Bilharz Research Institute , Egypt

Dr. Eman Sayed Shabrawy El-Wakil is an Associate Professor and Consultant of Medical Parasitology at the Theodor Bilharz Research Institute (TBRI), Egypt. Born on November 21, 1985, she has been deeply engaged in research and diagnostics of parasitic diseases, particularly focusing on molecular characterization, novel therapeutics, and gut microbiota-parasite interaction. With multiple peer-reviewed publications, she contributes to advancing parasitological science both in Egypt and internationally. She earned her M.D. in Medical Parasitology from Cairo University, and her scholarly reputation is supported by memberships and indexed profiles on ResearchGate, Google Scholar, Scopus, and ORCID. Dr. El-Wakil’s work has received notable accolades, including the prestigious TBRI award for the best doctoral research. She is also a reviewer for multiple journals and collaborates on multidisciplinary research tackling emerging parasitic threats. Her vision integrates research, education, and public health improvement through evidence-based parasitology.

Publication Profile:

Scopus

✅ Strengths for the Award:

Dr. Eman Sayed Shabrawy El-Wakil stands out as a prominent figure in Medical Parasitology, with an impressive track record in research, publication, and applied therapeutics. Her strengths include:

  • Robust Research Output: With over 12 peer-reviewed publications in high-impact international journals between 2023–2025, her work addresses critical parasitic diseases like Cryptosporidiosis, Trichinellosis, Toxoplasmosis, and Entamoeba infections.

  • Innovative Methodologies: She has pioneered green synthesis, nanoparticle-based therapies, in silico modeling, and immunomodulatory strategies, showcasing her multidimensional expertise.

  • Academic Leadership: As an Associate Professor and Consultant at TBRI, she contributes to teaching, mentoring, and national public health research priorities.

  • International Recognition: Indexed in Scopus, Google Scholar, ORCID, and Web of Science, and recipient of the TBRI Award for the best doctoral research in 2021.

  • Interdisciplinary Collaboration: Engaged in research across nanomedicine, pharmacology, microbiota-parasite interactions, and immunotherapy.

🔍 Areas for Improvement:

While Dr. El-Wakil’s profile is distinguished, some areas can be enhanced to strengthen her global impact:

  • Increased Global Engagement: Participation in more international collaborative projects, conferences, and consortia would amplify the reach of her research.

  • Grant Acquisition: Pursuing competitive research funding (e.g., WHO, NIH, EU Horizon) would facilitate larger-scale studies and clinical applications.

  • Patents and Translational Outputs: Exploring patenting opportunities for her innovative therapeutic agents could position her as a translational research leader.

🎓 Education:

Dr. El-Wakil earned her Master’s (M.Sc.) in Medical Parasitology with Excellent distinction in May 2015, and her Doctorate (M.D.) in Medical Parasitology in May 2018 from the Faculty of Medicine, Cairo University. Her educational path is marked by excellence in theoretical and applied parasitology, encompassing key disciplines like Molecular Parasitology, Immunology, and Medical Parasitology. Her M.D. thesis, titled “Isolation and Molecular Characterization of Free-Living Amoebae from Water Sources in Egypt”, reflected her early interest in environmental parasitology and public health. The academic structure of her doctoral program integrated critical courses in host-parasite interactions and advanced diagnostic techniques, equipping her with both field and laboratory expertise. Her education established a strong foundation for a career defined by innovation, critical thinking, and translational research in parasitic diseases.

💼 Experience:

Currently serving as an Associate Professor and Consultant at TBRI’s Parasitology Department, Dr. El-Wakil brings over a decade of expertise in diagnostics, molecular biology, and experimental parasitology. She operates within the Immunology and Drug Evaluation Division, where she contributes to therapeutic investigations and drug repurposing studies targeting helminths and protozoa. Her consultancy role extends to research mentorship, scientific reviews, and diagnostic innovations for parasitic infections in Egypt. She also works closely with governmental and academic institutions under the Ministry of Higher Education and Scientific Research. Her leadership roles in various inter-institutional projects have propelled the institute’s visibility in parasitology. She also manages collaborations involving nanotechnology, bioinformatics, and herbal medicine as potential parasitic treatments. Dr. El-Wakil exemplifies a blend of academic rigor and applied science, aligning her role with national health priorities and global research trends.

🏅 Honors and Awards:

Dr. El-Wakil was honored with the Theodor Bilharz Research Institute Award in 2021 for the best research derived from a doctoral dissertation—an acknowledgment of her innovation in parasitological research. This award recognized her pioneering work on free-living amoebae and her methodological precision. In addition to institutional awards, her research has been showcased in multiple open-access international journals, and she frequently receives commendations for excellence in experimental design and publication impact. Her work on novel anti-parasitic agents and immunotherapeutic approaches has attracted attention in scientific forums. She has also contributed to multi-author reviews on global health topics such as SARS-CoV-2 vaccines, highlighting her versatility as a researcher. Her awards reflect both her depth of knowledge and the real-world applicability of her research in enhancing public health outcomes.

🔬 Research Focus:

Dr. El-Wakil’s research concentrates on the epidemiology, molecular diagnostics, and therapeutic strategies for parasitic infections. Her work integrates natural product pharmacology, nanotechnology-based delivery systems, and immune modulation therapies. Her investigations cover a broad spectrum of parasites, from protozoa like Cryptosporidium and Entamoeba, to helminths such as Trichinella spiralis. Recent research includes green synthesis of nanoparticles, bioinformatics-based molecular docking, and gut microbiota-parasite interactions. A recurring theme in her research is the repurposing of existing drugs for parasitic treatment, evaluated both in vitro and in vivo. She also explores the interplay between host immunity and parasitic infection using molecular signaling pathways such as P2X7 receptors. Her focus on translational parasitology bridges basic research and therapeutic innovation, providing insights into both endemic and emerging infections in Egypt and beyond.

📚 Publications Top Notes:

  1. 🍊 Green Synthesis of Chitosan/Silver Nanoparticles Using Citrus paradisi Extract and Its Potential Anti-Cryptosporidiosis Effect

  2. 🧬 Microbiota-Parasite Interaction: Implication of Secretory Immunoglobulin A and P2X7 Receptor Signaling

  3. 🌿 Repurposing Drugs to Treat Trichinellosis: In Vitro Analysis of Nifedipine and Chrysanthemum coronarium Extract

  4. 🧪 Prevalence and Molecular Identification of Entamoeba Species Complex in Egyptians

  5. 📊 Mapping Gut Parasitism Patterns in a Cohort of Egyptians

  6. 🍃 Annona Muricata Leaf as an Anti-Cryptosporidial Agent: In Silico and In Vivo Study

  7. 🌼 Prophylactic and Therapeutic Effects of Kaempferol on Experimental Trichinella Spiralis

  8. 💊 Surfactant Vesicles for Enhanced Antitoxoplasmic Effect of Norfloxacin

  9. 🧾 SARS-CoV-2 Vaccines from A to Z: A Review of the Current Challenges

  10. 💉 Albendazole and Berberine Nanoparticles in Experimental Trichinellosis

  11. 🌿 Therapeutic Efficacy of Silymarin on Intestinal and Muscular Phases of Trichinellosis

  12. 🧫 Trichinella spiralis Antigens for Inflammatory Bowel Disease: Immunotherapeutic and Prophylactic Potential

🧾 Conclusion:

Dr. Eman S. El-Wakil demonstrates excellence in research productivity, scientific innovation, and professional engagement. Her contributions to parasitology—especially in the field of therapeutic innovation using natural compounds and nanoparticles—mark her as an emerging leader in her field. Given her academic rigor, publication record, and commitment to tackling parasitic diseases of global health concern, she is an outstanding candidate for the Best Researcher Award.

Marcio Rodrigues | Microbial Cell Biology | Pioneer Researcher Award

Posted on by Cell Biologist

Dr. Marcio Rodrigues | Microbial Cell Biology | Pioneer Researcher Award

Dr. Marcio Rodrigues , Fiocruz , Brazil

Dr. Marcio L. Rodrigues is a distinguished Senior Investigator at the Carlos Chagas Institute of Fiocruz, specializing in fungal infections. His pioneering work in fungal extracellular vesicles (EVs) has revolutionized the understanding of fungal secretion mechanisms and antifungal drug development. With an extensive background in microbiology and pharmaceutical sciences, Dr. Rodrigues has made groundbreaking contributions to Cryptococcus research. He has held editorial roles at prestigious journals, coordinated major research programs, and received numerous accolades, including a Fellowship at the Brazilian Academy of Sciences. His research has significantly impacted global fungal disease studies, earning him recognition as a leader in the field.

Publication Profile:

Orcid

Strengths for the Award:

✅ Pioneering Contributions – Dr. Rodrigues has significantly advanced fungal microbiology, particularly in the field of fungal extracellular vesicles (EVs), a groundbreaking area of study.
✅ Extensive Research Output – His prolific publication record in high-impact journals like Nature Microbiology and mBio reflects the depth of his contributions.
✅ Leadership & Editorial Roles – His position as an editor for Current Topics in Microbiology and Immunology and ASM’s mBio demonstrates his influence in the scientific community.
✅ International Recognition – His fellowships and awards, including the Wellcome Trust Pathfinder Award and recognition by The World Academy of Science (TWAS), highlight his global impact.
✅ Funding & Program Coordination – As a coordinator of the Inova Funding Program at Fiocruz, he plays a crucial role in fostering research and innovation.

Areas for Improvement:

🔹 Industry Collaboration – While his research is academically impactful, expanding collaborations with biotechnology and pharmaceutical companies could enhance the translational applications of his findings.
🔹 Public Outreach & Policy Advocacy – Increasing public engagement and involvement in global health policy discussions on fungal infections would further solidify his influence beyond academia.
🔹 Interdisciplinary Expansion – Bridging fungal biology with AI-driven bioinformatics or immunotherapy could push his research into newer frontiers.

Education:

🎓 Federal University of Rio de Janeiro
🔹 PHMD (1995) – Pharmaceutical Sciences
🔹 PhD (2000) – Microbiology

Dr. Rodrigues pursued his higher education at the Federal University of Rio de Janeiro, obtaining a PHMD in Pharmaceutical Sciences in 1995. He further specialized in Microbiology, completing his PhD in 2000. His academic training provided a strong foundation for his career in medical mycology, particularly in studying fungal pathogens. His doctoral research focused on the biology of Cryptococcus neoformans, paving the way for his later work in fungal extracellular vesicles (EVs) and their role in pathogen virulence and drug resistance.

Experience:

🔬 Senior Investigator, Carlos Chagas Institute, Fiocruz
📖 Editor, Current Topics in Microbiology and Immunology (Springer)
📝 Mini-review Editor, ASM’s mBio
💡 Coordinator, Inova Funding Program, Fiocruz

With over two decades of research experience, Dr. Rodrigues has established himself as a global leader in fungal biology and infectious diseases. As a Senior Investigator at Fiocruz, he leads studies on fungal EVs, antifungal resistance, and molecular microbiology. His editorial roles in high-impact journals underscore his expertise in the field, while his coordination of research funding programs demonstrates his commitment to advancing mycology research.

Awards & Honors:

🏆 Pathfinder Award (2014-2016) – The Wellcome Trust, UK
🌍 Young Affiliate (2011-2015) – The World Academy of Science (TWAS)
🇧🇷 Fellow (2024) – Brazilian Academy of Sciences

Dr. Rodrigues has received prestigious awards for his contributions to fungal pathogenesis and drug discovery. His recognition as a Pathfinder Awardee by The Wellcome Trust and a Young Affiliate of TWAS highlights his impact on global infectious disease research. In 2024, he was elected a Fellow of the Brazilian Academy of Sciences, reinforcing his standing as a leading researcher in microbiology.

Research Focus:

🦠 Fungal Extracellular Vesicles (EVs)
💊 Antifungal Drug Discovery
🔬 Cryptococcus neoformans Pathogenesis
🧫 Molecular Mechanisms of Fungal Infections

Dr. Rodrigues’ research has been instrumental in uncovering the role of fungal EVs in pathogen virulence and host interactions. His work has led to novel insights into fungal secretion mechanisms and drug resistance, contributing to the development of new antifungal therapies. His studies on Cryptococcus species have provided crucial data for the medical mycology field, enhancing diagnostic and therapeutic strategies for fungal infections.

Publications Top Notes:

📜 Proteomics reveals that the antifungal activity of fenbendazole against Cryptococcus neoformans requires protein kinases – International Journal of Antimicrobial Agents, 2024
📜 Screening of the Pandemic Response Box reveals an association between antifungal effects of MMV1593537 and the fungal cell wall – Microbiol Spectr, 2022
📜 A general analysis of the impact of international collaboration on scientific citations – Anais da Academia Brasileira de Ciências, 2025
📜 Characterizing extracellular vesicles of human fungal pathogens – Nature Microbiology, 2025
📜 Introducing mGems, mBio’s new review type – mBio, 2025
📜 Effects of human immunoglobulin A on Cryptococcus neoformans morphology and gene expression – Microbiology Spectrum, 2025
📜 Preparation of biologically active fractions enriched with glucuronoxylomannan, the main antigen of the cryptococcal capsule – 2024 (Book Chapter)
📜 Extracellular Vesicles from Scedosporium apiospermum and fungal-host interactions – Journal of Fungi, 2024
📜 Funding for research on cryptococcal disease: an analysis based on the G-finder report – IMA Fungus, 2024
📜 The multiple frontiers in the study of fungal extracellular vesicles – Microbes and Infection, 2024
📜 A tribute to Professor Luiz R. Travassos: Lessons from a scientist (1938–2020) – Brazilian Journal of Microbiology, 2023

Conclusion:

Dr. Marcio L. Rodrigues is an exceptionally strong candidate for the Pioneer Researcher Award due to his groundbreaking discoveries, prolific publication record, leadership roles, and international recognition. His work on fungal extracellular vesicles and antifungal development has significantly shaped the field, making him a deserving recipient of this prestigious award.

Romain Villéger | Host-bacteria interactions | Cell Metabolism Award

Posted on by Cell Biologist

Assist. Prof. Dr. Romain Villéger | Host-bacteria interactions | Cell Metabolism Award

Assist. Prof. Dr. Romain Villéger , Université de Poitiers , France

Dr. Romain Villéger is an Assistant Professor at the University of Poitiers, France, in the Ecology & Biology of Interactions (EBI) lab, within the Microorganisms-Hosts-Environments (MHE) team. With a Ph.D. from the University of Limoges, his work explores the intricate interactions between probiotics and host cells. He has held postdoctoral positions at the University of Bordeaux and the University of Texas Medical Branch, USA, focusing on microbiota-host relationships and metabolomics. Dr. Villéger’s research aims to unravel the role of bacterial interactions, particularly in the context of gastrointestinal health, microbiota, and cancer. His research has led to significant advancements in understanding microbial pathogenesis, including the effects of probiotics and endocrine disruptors on host cell metabolism. A dedicated researcher, he has contributed to numerous scientific publications and currently leads several high-impact projects on bacteria-host interactions.

Publication Profile:

Scopus

Strengths for the Award:

  1. Expertise in Metabolomics: Dr. Romain Villéger’s extensive work in metabolomics, especially in the context of host-bacteria interactions, positions him as a strong candidate for the Cell Metabolism Award. His research on bacterial influence on host cellular metabolism and gut microbiota interactions contributes significantly to the field of cellular metabolism.
  2. Innovative Research Contributions: His research, particularly on the metabolic changes during amoeba-Legionella interactions, showcases a novel approach to understanding microbial pathogenesis. By identifying metabolic vulnerabilities in pathogens, his work has the potential for therapeutic applications, thus addressing fundamental questions in cell metabolism.
  3. Multidisciplinary Approach: Dr. Villéger combines microbiology, immunology, and metabolomics, which enriches his contributions to cellular metabolism. His research is collaborative, evidenced by numerous projects across different institutions and fields, indicating a broad and innovative approach to the subject.
  4. Publications and Impact: He has a strong publication record, with numerous articles in peer-reviewed journals (19 publications), with high visibility in top-tier journals such as British Journal of Cancer, Frontiers in Cellular and Infection Microbiology, and Environmental Microbiology Reports. This demonstrates his influence and impact in the scientific community.
  5. Research Leadership: As the principal investigator of multiple projects, including those on the effects of phthalates on gut microbiota and cancer development, Dr. Villéger has demonstrated leadership in advancing scientific knowledge in areas that intersect with cell metabolism, host-microbe interactions, and metabolic changes in disease.

Areas for Improvement:

  1. Broader Clinical Translation: While his research shows deep insights into fundamental mechanisms, further work on translating these findings into practical clinical applications or therapeutic interventions would strengthen his impact in applied cellular metabolism.
  2. Interdisciplinary Team Development: While Dr. Villéger collaborates with many renowned researchers, fostering additional interdisciplinary partnerships could enrich his research by incorporating diverse techniques and perspectives from fields like drug development or personalized medicine.
  3. Expanding Metabolomic Toolkits: His research could benefit from exploring emerging and cutting-edge techniques in metabolomics, like single-cell analysis or multi-omics approaches, to gain deeper insights into cellular metabolism at the individual cell level.

Education:

Dr. Villéger completed his Ph.D. at the University of Limoges, where his thesis focused on the interactions between probiotics and host cells. His postdoctoral work spans institutions in France, the USA, and beyond, each contributing valuable insights into microbial-host dynamics and cellular microbiology. At the University of Bordeaux, he developed metabolomic approaches using GC/MS to study microbiota interactions. Later, at the University of Texas Medical Branch, he delved deeper into the effects of probiotics on intestinal homeostasis. Further postdoctoral experiences at the University of Clermont Auvergne involved examining the relationship between E. coli and colorectal cancer. Through these experiences, Dr. Villéger has gained expertise in microbiota research, cell biology, and metabolic analysis, providing a foundation for his ongoing work in the field. His education has provided a strong interdisciplinary framework, integrating microbiology, molecular biology, and toxicology into his research.

Experience:

Dr. Villéger has accumulated extensive experience in both academic and research settings. After earning his Ph.D. in 2014, he completed several postdoctoral positions, with notable work at the University of Bordeaux, where he pioneered metabolomics techniques for microbiota research. His tenure at the University of Texas Medical Branch expanded his focus to the effects of probiotics on intestinal homeostasis. Additionally, his work at the University of Clermont Auvergne involved exploring the connection between microbial interactions and cancer. Since joining the University of Poitiers in 2020 as an Assistant Professor, Dr. Villéger has led several research projects, including investigating the impact of endocrine disruptors on colorectal cancer development. He is also a leader in metabolomics and microbial pathogenesis, with a particular focus on bacteria-host interactions and microbiota modulation. His research has contributed to numerous publications and collaborations with institutions worldwide, showcasing his ability to manage complex research projects.

Research Focus:

Dr. Villéger’s research primarily focuses on bacteria-host interactions, gut microbiota, and cellular microbiology, with a special interest in how microbial populations affect host metabolism. His work integrates metabolomics, a powerful tool for studying metabolic processes, to better understand microbial influence on host cells. Dr. Villéger’s recent studies explore the role of oxidative stress in microbial infections, including Legionella pneumophila’s subversion of host immune defenses during infection. He has also investigated the impact of endocrine disruptors on microbial virulence, providing insights into the potential links between environmental factors and microbial pathogenesis. His contributions to understanding the microbiota-gut-brain axis, particularly in the context of colorectal cancer, emphasize the metabolic changes induced by bacterial interactions. Dr. Villéger’s research aims to identify biomarkers for disease and therapeutic interventions, with a broader goal of advancing precision medicine through a better understanding of the cellular and metabolic processes that underlie microbial-host dynamics.

Publications Top Notes:

  1. Legionella pneumophila subverts the antioxidant defenses of its amoeba host Acanthamoeba castellanii 💥🦠
  2. Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn’s Disease 🔬🧬
  3. Exposure to endocrine disruptors promotes biofilm formation and contributes to increased virulence of Pseudomonas aeruginosa 💧🦠
  4. Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer 🧬🦠
  5. Effect of endocrine disruptors on bacterial virulence 🌿🧪
  6. Proteomic analysis of Acanthamoeba castellanii response to Legionella pneumophila infection 🔬🦠
  7. Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism 🧬🍊
  8. Microbiota medicine: towards clinical revolution 🌍💊
  9. Deletion of cystathionine-γ-lyase in bone marrow-derived cells promotes colitis-associated carcinogenesis 🔬🦠
  10. Prebiotic Isomaltooligosaccharide Provides an Advantageous Fitness to the Probiotic Bacillus subtilis CU1 🍞🦠

Conclusion:

Dr. Romain Villéger is a highly qualified candidate for the Cell Metabolism Award. His research contributions in understanding microbial influence on cellular metabolism and gut health, combined with his innovative approach to metabolomics, make him stand out in the field. His work bridges basic science and potential clinical applications, positioning him as a key figure in the ongoing exploration of microbial and metabolic influences on host physiology. With some expansion into clinical applications and further exploration of new metabolomics techniques, his contributions could significantly impact both scientific knowledge and medical practice.